Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial.
Vincent LabbéDamien ContouNicholas HemingBruno MegarbaneHafid Ait-OufellaFlorence BoissierSerge CarreiraAlexandre RobertEmmanuel VivierMohamed FejjalDenis DoyenMehran MonchiSebastien PreauElise Noel-SavinaBertrand SouweineNoémie ZucmanSantiago Alberto PicosMartin DresWilliam JuguetEric MariotteJean-François TimsitMatthieu TurpinKeyvan RazaziSégolène GendreauSamia BaloulGuillaume VoiriotMuriel FartoukhEtienne AudureauArmand Mekontso DessapPublished in: BMJ open (2022)
NCT04808882.
Keyphrases
- study protocol
- open label
- randomized controlled trial
- coronavirus disease
- clinical trial
- sars cov
- atrial fibrillation
- venous thromboembolism
- phase ii
- phase iii
- phase ii study
- early onset
- cross sectional
- respiratory syndrome coronavirus
- drug induced
- radiation therapy
- squamous cell carcinoma
- placebo controlled
- clinical evaluation
- rectal cancer